Skip to content
Open access

Dexamphetamine-induced striatal hyperdopaminergia attenuates reward-related neural activation: A11C-PHNO PET-fMRI study.

Sep 2026 · Biological Psychiatry · 0 citations · 49 references
Medicine

Abstract

Background

Ventral striatum (VS) and ventromedial prefrontal cortex (vmPFC) encode the value of stimulus and outcome phases in a context-dependent manner to support motivated behaviour. In psychosis, disrupted motivational coding has been hypothesised to contribute to negative symptoms via reduced sensitivity to goal-relevant information, potentially linked to elevated striatal dopamine. Direct causal evidence for this mechanism in humans remains limited.

Methods

Healthy volunteers (N=28) underwent two simultaneous [11C]-PHNO PET-fMRI sessions (placebo; oral dexamphetamine 0.5 mg/kg, double-blind, randomised crossover). During scanning, participants performed a decision-making task requiring trial-by-trial use of contextual cues to discriminate reward-predictive (relevant) from non-predictive (irrelevant) stimulus features. fMRI quantified context-relevant value coding during reward anticipation and positive-negative outcome responses. PET quantified D2/3 agonist binding potential (BPND) and dexamphetamine-induced dopamine release (ΔBPND). Mixed-effects models related BOLD responses to between- and within-subject components of BPND.

Results

Task performance was high with no behavioural drug effects. Under placebo, VS showed greater activation to context-relevant versus irrelevant value during anticipation. Dexamphetamine significantly attenuated this effect, driven by reduced VS responses to relevant cues without increased responses to irrelevant features. Dexamphetamine also reduced outcome-related responses in VS; non-significantly in vmPFC. Across sessions, higher between-subject [11C]-PHNO BPND was associated with stronger VS reward coding during anticipation and outcome, whereas within-subject BPND deviations did not explain additional variance beyond drug condition.

Conclusions

These findings support a mechanism by which elevated dopamine may impair motivational coding by reducing amplification of goal-relevant information, with potential relevance to negative symptoms such as apathy and anhedonia.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.